VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe
CONCLUSIONS: The VACCELERATE Site Network enables a constantly updated Europe-wide mapping of experienced clinical sites interested in executing vaccine trials. The network is already in use as a rapid-turnaround single contact point for the identification of vaccine trials sites in Europe.PMID:37210309 | PMC:PMC10194816 | DOI:10.1016/j.vaccine.2023.05.006
Source: Vaccine - Category: Allergy & Immunology Authors: Jon Salmanton-Garc ía Pauline Wipfler Paula Valle-Sim ón Christina Merakou Ioannis Kopsidas Ullrich Bethe Angela Steinbach Orly Spivak Lenka Sou čková Maria Am élia Mendonça Markela Koniordou Margot Hellemans Jesus Fr ías-Iniesta Ruth Joanna Davis Source Type: research
More News: Academia | Allergy & Immunology | Clinical Trials | Infectious Diseases | Influenza | Influenza Vaccine | Men | Monkeypox | Pediatrics | Pneomococcal Vaccine | SARS | Study | Vaccines